13.45
+1.56
+(13.12%)
At close: January 24 at 4:00:00 PM EST
13.45
0.00
(0.00%)
After hours: January 24 at 4:01:03 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-3,581.40
-1,180.87
-1,257.10
-1,586.72
Investing Cash Flow
-258.55
-311.17
-87.21
-312.25
Financing Cash Flow
3,599.33
1,000.00
1,355.07
2,312.42
End Cash Position
233.94
66.53
558.57
547.81
Income Tax Paid Supplemental Data
105.83
63.56
--
--
Capital Expenditure
-295.79
-288.71
-185.98
-422.59
Issuance of Capital Stock
--
--
1,355.07
2,312.42
Free Cash Flow
-3,877.19
-1,469.58
-1,443.08
-2,009.31
12/31/2021 - 11/13/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CUE Cue Biopharma, Inc.
1.4900
+7.19%
SEPN Septerna, Inc.
18.48
+0.54%
ACOG Alpha Cognition Inc. Common Stock
6.55
+4.47%
RYTM Rhythm Pharmaceuticals, Inc.
57.78
-1.18%
MBX MBX Biosciences, Inc.
10.75
-8.35%
FENC Fennec Pharmaceuticals Inc.
6.23
+3.49%
RAPP Rapport Therapeutics, Inc.
13.90
-2.59%
COEP Coeptis Therapeutics Holdings, Inc.
11.91
+22.28%
IBO Impact BioMedical Inc.
1.7690
+12.68%
CRGX CARGO Therapeutics, Inc.
13.46
-2.75%